Itama Ranoraya - Asset Resilience Ratio

Latest as of September 2022: 1.56%

Itama Ranoraya (IRRA) has an Asset Resilience Ratio of 1.56% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Itama Ranoraya for a breakdown of total debt and financial obligations.

Liquid Assets

Rp12.09 Billion
≈ $708.45K USD Cash + Short-term Investments

Total Assets

Rp777.22 Billion
≈ $45.54 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Itama Ranoraya's Asset Resilience Ratio has changed over time. See what is Itama Ranoraya's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Itama Ranoraya's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Itama Ranoraya market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rp12.09 Billion 1.56%
Short-term Investments Rp0.00 0%
Total Liquid Assets Rp12.09 Billion 1.56%

Asset Resilience Insights

  • Limited Liquidity: Itama Ranoraya maintains only 1.56% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Itama Ranoraya Industry Peers by Asset Resilience Ratio

Compare Itama Ranoraya's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
Medical Distribution 1.77%
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%

Annual Asset Resilience Ratio for Itama Ranoraya (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Itama Ranoraya.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.00% Rp0.00
≈ $0.00
Rp1.06 Trillion
≈ $62.05 Million
--
2021-12-31 0.00% Rp0.00
≈ $0.00
Rp782.04 Billion
≈ $45.82 Million
--
2020-12-31 21.48% Rp115.00 Billion
≈ $6.74 Million
Rp535.27 Billion
≈ $31.36 Million
-9.24pp
2019-12-31 30.73% Rp100.00 Billion
≈ $5.86 Million
Rp325.43 Billion
≈ $19.07 Million
+21.19pp
2018-12-31 9.54% Rp13.00 Billion
≈ $761.75K
Rp136.26 Billion
≈ $7.98 Million
-16.31pp
2017-12-31 25.85% Rp33.00 Billion
≈ $1.93 Million
Rp127.67 Billion
≈ $7.48 Million
--
2016-12-31 0.00% Rp0.00
≈ $0.00
Rp27.20 Billion
≈ $1.59 Million
--
pp = percentage points

About Itama Ranoraya

JK:IRRA Indonesia Medical Distribution
Market Cap
$34.10 Million
Rp582.02 Billion IDR
Market Cap Rank
#23272 Global
#485 in Indonesia
Share Price
Rp386.00
Change (1 day)
-1.53%
52-Week Range
Rp376.00 - Rp530.00
All Time High
Rp3619.99
About

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more